Strides Pharma to acquire, in-license Sandoz generic brands in Africa for $12 million upfront
Strides Pharma to acquire, in-license Sandoz generic brands in Africa for $12 million upfront
Strides Pharma to acquire, in-license Sandoz generic brands in Africa for $12 million upfront
Sector
HEALTHCARE
News Type
MARKET
Impact Level
LOW
AI Sentiment
NEUTRAL
Published
04 May 2026
📎 Sources
CNBC TV18 | https://www.tradingview.com/news/cnbctv:66a3e687c094b:0/